Blog TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif., (Oct. 20, 2022) – Amgen (NASDAQ: AMGN)
Blog The US Food and Drug Administration (FDA) has granted approval for Regeneron Pharmaceuticals and Sanofi’s Kevzara (sarilumab) to treat polymyalgia rheumatica (PMR) in adult
Blog Newswise — ATLANTA — The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released a new guideline for the management
Blog FOR IMMEDIATE RELEASE July 9, 2021 Media Contact Amanda Head (Corna) acorna@rheumatology.org 404-679-5330 The American College of Rheumatology/Vasculitis Foundation Release Three New Guidelines for Treatment
Blog ChemoCentryx Announces Filing of Amendment to NDA Submission and Extension of the PDUFA Review Period for Avacopan in the Treatment of ANCA-Associated Vasculitis SAN
